More recently, it has been reported that anti-CTLA-4 therapy induces the expansion of melanoma-infiltrating ICOS+ TH1-like CD4+ T cells as well as exhausted-like CD8+ T cells [38]. The gene discussed is ICOS; the disease is melanoma.